JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
Clinical trial NCT06386146 · RECRUITING
Trial details
- NCT number
- NCT06386146
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2027-01-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.